SUMMARY A male patient with Wilson's disease developed a hepatocellular carcinoma after treatment for nine years with D-penicillamine. Examination at necropsy showed that excess liver copper had been effectively removed. As copper has been shown to protect against chemically induced hepatocellular carcinoma in rats, this may be the reason for the extreme rarity of hepatocellular carcinoma in patients with Wilson's disease and possibly in other liver diseases with hepatic copper overload.
Hepatocellular carcinoma is a common complication of longstanding cirrhosis and, overall, the likelihood of this in any particular aetiological group of patients has been said to depend on the proportion of men within that group and the duration of cirrhosis. At one end of the spectrum are patients with haemochromatosis or HBsAg positive cirrhosis who are predominantly male and at the other end are those with primary biliary cirrhosis or HBsAg negative chronic active hepatitis with very few men affected.' It is therefore suprising that in Wilson's disease (hepatolenticular degeneration) which has an even sex incidence and a substantial proportion of patients surviving for long periods, there have only been two proven cases and one possible further instance. [2] [3] [4] In this paper we describe a fourth case and discuss the relationship between the development of hepatocellular carcinoma and the protective role of copper overload which has been shown experimentally.
Case history
A 31 year old male chemical engineer was referred to the Liver Unit in December 1971 after an episode of melaena. There had been previous episodes in 1968 and 1969. He had recently noticed mental fuzziness and difficulty in concentrating at work and on examination Kayser-Fleischer rings and hepato-Received for publication 14 October 1982 splenomegaly were present. Investigations showed a serum bilirubin concentration of 10.3 ,umol/l (0.6 mg/dl); aspartate aminotransferase 34 IU (normal <50 LU); alkaline phosphatase 55 IU (normal <100 LU); albumin 30 g/l; total protein 53 g/l; and prothrombin time 17 seconds (control 12 seconds). Immunoglobulins, autoantibodies, HBsAg, and alphafetoprotein were normal or negative.
Hepatic arteriogram and splenic venogram showed gastric and oesophageal varices with patent splenic and portal veins. Electroencephalogram was normal.
The diagnosis of Wilson's disease was confirmed by the finding of a zero serum caeruloplasmin concentration on two occasions, a low serum copper concentration of 0.8 ,umol/l (5 ug/dl) and 1.3 ,umol/l (8.1 ,@g/dl). Urinary copper was 0.94 umol (58.9 ,gg) and 1.15 ,mol (72 ,ug) per 24 hours (normal <0-8 ,umol (50 ,ug)/24 h) before and 6-65 ,umol (410 gg) per 24 hours after D-penicillamine. Investigations of the family revealed a low caeruloplasmin and raised urinary copper excretion in his sister (who was subsequently treated with D-penicillamine) with normal concentrations in both parents.
In January 1972 a lienorenal anastomosis was performed and he was started on D-penicillamine therapy. This was continued for the next nine and a half years at dosages ranging from 725 to 900 mg daily (Fig. 1 ). In 1973 he had a minor episode of encephalopathy and in 1980 he developed fluid retention which was thereafter controlled by spironolactone. He was otherwise well and in full time On examination he was in g encephalopathy. The liver was palpable 2 the costal margin and there were signs o patchy chest consolidation but no focal ne signs. Investigations showed little chang function tests compared with June 1981 ( serum bilirubin which had risen to 162 ,u markers for hepatitis B virus were ne radioimmunoassay. There was initia improvement in conscious level; howeve further convulsions, bronchopneumonia iliofemoral thrombosis developed, and 1 level of coma deepened. He died on 1981.
HISTOLOGY OF LIVER
The first percutaneous liver biopsy ta operatively in 1971 ( Fig. 2 ) showed a v lished cirrhosis with prominent cellular ar pleomorphism including ballooned frequent nuclear vacuolations with microvesicular transformation of the cytc places there were larger foci of fatty vacuo of iron deposition. There was some ne inflammation, mostly confined to the fibro with only patchy disruption of the limit Orcein staining revealed finely divided g copper-associated protein in large groups of cells patchily and randomly distributed. The wedge biopsy specimen showed the same features and confirmed the presence of micronodular cirrhosis.
Follow up biopsy showed a more collapsed liver with broader bands of inflamed connective tissue surrounding small hyperplastic nodules. Perls' stain revealed grade I siderosis with an irregular distribution. Orcein staining was negative.
At necropsy the lienorenal shunt was patent and .
the inferior vena cava was normal. There were dilated tortuous veins in the lower oesophagus but no blood within the gastrointestinal tract. The Jan 1980 surface of the liver showed micronodular cirrhosis. It weighed 1502 g and on sectioning there were large ion over haemorrhagic nodules up to 5 cm in diameter ( Fig.   e death. 0-8 3) . There was no evidence of tumour in any other organ. Histological examination showed nodules composed of a well-differentiated hepatocellular carcinoma of trabecular pattern with evidence of )egan with bile formation (Fig. 4) . On orcein staining of the 1981 and surrounding liver in contrast to the initial biopsy but ,pital after similar to the one taken one year before death, very g day he few cells or groups of cells contained copper-binding ventilation protein, usually those cells enmeshed in fibrous a further tissue. Liver copper level was 48 mg/100 g dry ts, and he weight (normal <50 mg/100 g) as determined by ospital in flame photometry at the National Hospital for Nervous Diseases, Queen Square, London.
;rade II cm below Discussion f bilateral urological One possible explanation for the low incidence of re in liver hepatocellular carcinoma in patients with Wilson's except for disease is that the presence of copper in the mol/l. All hepatocytes protects them from the oncogenic gative by consequences of cirrhosis. There have been several flly some reports showing protection by increased dietary r, he had copper from chemically included hepatic carcinoand an genesis in rats.8 If this mechanism operates in finally his Wilson's disease protection could be reversed once 5 October the excess copper has been removed by treatment but the time needed to remove excess copper by chelation therapy is not accurately known.
Sherlock9 stated that complete decoppering is iken pre-unusual even after many years of treatment and vell estab-according to Walshel0 the speed of decoppering nd nuclear depends on the dose of penicillamine, many patients cells and managing on 900 mg/day but some requiring 2-3 peripheral g/day to remain in negative copper balance.
)plasm. In Another factor is dietary intake which is usually slation and from 2-5 mg/day but with water supplied in copper on-specific pipes, shellfish, nuts, chocolate, and some other ous areas, foods this figure may be much higher. The only ting plate. certain indication that 'decoppering' is adequate is a ,ranules of repeat chemical estimation of copper in liver tissue. Thus our present patient had no histochemical evidence of copper overload 21 months before death (although he was still excreting over 5 ,imol/24 h in his urine (Fig. 1) ) and a tissue copper estimation performed after death showed the concentration to be at the upper end of the normal range. This suggests that a normal tissue copper concentration was only achieved towards the end of the nine year treatment period. Some increase in liver copper may occur in the late stages of cirrhosis from any aetiology"1 and the level at which intrahepatic copper deposits are protective in vivo is unknown. Considerable excess hepatic copper is also present from an early stage in certain chronic cholestatic conditions, especially primary biliary cirrhosis in which hepatocellular carcinoma has been reported only rarely. 12 As it is predominantly a disease of women this also has to be taken into account. The latter does not apply, however, to primary sclerosing cholangitis'3 in which we have been unable to find any reports of associated hepatocellular carcinoma and such considerations may have added relevance now that penicillamine is being used in the treatment of these patients as well as in primary biliary cirrhosis.
